Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women

Table 4 Quartiles of soluble receptor for advanced glycation end products

Frequency distribution of CAD and control in sRAGE quartile categories
sRAGE (pg/mL)		Group		Total	P value
		Case	Control
< 225	n	24	4	28	19.16/0.00b
	%	43.6	7.3	25.5
≥ 225-< 397.5	n	8	19	27	5.9/0.01a
	%	14.5	34.5	24.5
≥ 397.5-< 730	n	13	15	28	0.19/0.66
	%	23.6	27.3	25.5
≥ 730	n	10	17	27	2.4/0.12
	%	18.2	30.9	24.5
Total	n	55	55	110
	%	100.0	100.0	100.0

^aP < 0.05.

^bP < 0.01 (χ² test).

CAD: Coronary artery disease; sRAGE: Soluble receptor for advanced glycation end products.